MedDataX Logo

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

NCT ID: NCT00265408

Last Updated: 2014-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE1

Study Classification

INTERVENTIONAL

Study Start Date

2005-12-31

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

20 patients with cervicocephalic arterial dissection will be randomized to open-label aspirin or warfarin, rate of stroke and adverse events will be endpoints.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cervicocephalic Arterial Dissection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aspirin

Group Type EXPERIMENTAL

aspirin

Intervention Type DRUG

warfarin

Group Type EXPERIMENTAL

warfarin

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

aspirin

Intervention Type DRUG

warfarin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical and imaging diagnosis of cervicocephalic arterial dissection within 3 months.

Exclusion Criteria

* Any contraindication to aspirin or warfarin.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, San Diego

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matt B Jensen, MD

Role: PRINCIPAL_INVESTIGATOR

UCSD Stroke Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UCSD Medical Center

San Diego, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UCSD IRB #051253

Identifier Type: -

Identifier Source: org_study_id